Conference Coverage

ACE inhibitors may improve neuropsychiatric lupus

Publish date: April 13, 2019

 

REPORTING FROM LUPUS 2019

Pages

Recommended Reading

FDA panel leans toward more robust breast implant surveillance
MDedge Rheumatology
FDA panel calls for changes to breast implant rupture screening
MDedge Rheumatology
Rituximab does not improve fatigue symptoms of ME/CFS
MDedge Rheumatology
Mycophenolate, cyclophosphamide found equal as induction therapy in pediatric lupus nephritis
MDedge Rheumatology
Powerful breast-implant testimony constrained by limited evidence
MDedge Rheumatology
Tackling the challenges of pediatric localized scleroderma
MDedge Rheumatology
Bronchiolitis is a feared complication of connective tissue disease
MDedge Rheumatology
EULAR takes SLE guidance to the next level
MDedge Rheumatology
Expert gives tips on timing, managing lupus pregnancies
MDedge Rheumatology
Atmospheric fluctuations tied to lupus flares
MDedge Rheumatology